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1. Introduction 
Within the past decade, the list of publications involving mitochondrial dysfunction in the 
etiology of metabolic disorders in obesity, insulin resistance and type 2 diabetes, has been 
growing steadily. Today, large controversies still exist and it is clear that the understanding 
of the causes and consequences of impairments in mitochondrial functioning are far from 
being accomplished. In this context, our purpose is to review techniques used in human 
samples to highlight defects in mitochondrial activity, with a particular focus on skeletal 
muscle. Several tools are described to assess a large array of mitochondrial functions. In 
order to facilitate the reading of the review, several details related to methodological 
concerns are provided in supplementary materials and remain available upon request to the 
authors. 
2. Basic knowledge on mitochondrial functioning 
Mitochondria are found in nearly all eukaryotes. They are forming a complex network 
which shape and functioning is determined by the interaction with the cytoskeleton and by 
the balance between fusion and fission reactions (Zorzano et al., 2009). They vary in number 
and location according to cell type. Within skeletal muscle fibers, mitochondrial density and 
activity mainly varies according to fiber types and physical training (Howald et al., 1985) 
although type 2 diabetes and genetic inheritance have been also proposed as potential 
modulators (Petersen et al., 2004; Morio et al., 2005; Befroy et al., 2007). Mitochondria are 
located either around the nuclei, this subgroup is called subsarcolemmal mitochondria, or 
nestled between myofibrils. These mitochondria are named intermyofibrillar and have 
distinct activity from subsarcolemmal ones (Koves et al., 2005; Mollica et al., 2006). 
Intermyofibrillar mitochondria are mainly dedicated to energy production for muscle fiber 
contraction. By contrast, subsarcolemmal mitochondria may play a key role in signal 
transduction and substrate transport. Deficiency in the latter pool has been proposed to 
contribute to the pathogenesis of muscle insulin resistance in type 2 diabetes (Ritov et al., 
2005; Benton et al., 2008). 
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The most prominent role of mitochondria is to produce the “energy carrier” adenosine 
triphosphate (ATP) mainly from glucose and fatty acid oxidation, and to a lesser extend 
from amino acid oxidation. Nutrient oxidation within the cytosol and/or the mitochondrial 
matrix results in acetyl-CoA production, the main substrate of the tricarboxylic acid (TCA) 
cycle which takes place in the mitochondrial matrix. The β-oxidation pathway is specific to 
fatty acid oxidation and results in acetyl-CoA production which feeds TCA cycle. These 
oxidative pathways are coupled to the mitochondrial electron transport chain (ETC), whose 
enzyme content and activity together define the mitochondrial oxidative capacity. The latter 
factor combined with mitochondrial density determines the tissue oxidative capacity. The 
main rate-limiting oxidative enzymes are citrate synthase and isocitrate dehydrogenase 
(TCA cycle), -hydroxyacyl-CoA dehydrogenase (β-oxidation) and cytochrome c oxidase 
(ETC). Mitochondria are also key organelles for regulation of cell metabolism. Mitochondrial 
functioning has been proven to control cellular metabolism, redox and calcium signalling, 
apoptosis-programmed cell death and cellular proliferation. This shows that a perpetual 
cross talk exists between cell and mitochondria, the result being the cell adaptation to 
physiological changes or the cell death (Figure 1). 
Calcium signalling
Redox signalling
ATP production
Apoptosis programmed
cell death
Cell proliferation
Nutrient oxidation
Regulation of cell metabolism
Nucleus
Regulation of mitochondrial
functioning
mitochondrion
 
Fig. 1. Involvement of the cross-talk between nucleus and mitochondria in the regulation of 
cell adaptations. 
2.1 Mitochondrial respiratory chain, membrane potential and energy production, and  
main alterations observed in metabolic disorders 
Nutrient oxidation consists in a series of enzyme-catalysed oxidative reactions which aims 
at transferring energy-rich electrons to the cofactors nicotinamide adenine dinucleotide 
[NAD+] and flavin mononucleotide [FAD], forming respectively NADH, H+ and FADH2. 
The latter reduced carriers provide thereafter the ETC with these energy-rich electrons. The 
ETC is situated into the mitochondrial inner membrane and consists of four large enzyme 
complexes (Complex I, NADH-CoQ oxidoreductase; II, succinate dehydrogenase; III, CoQ-
cytochrome c oxidoreductase; and IV, cytochrome c oxidase). Mobile electron carriers (e.g. 
coenzyme Q or ubiquinone, and cytochrome c) transport the electrons from one complex to 
the next with oxygen acting as the final electron acceptor within cytochrome c oxidase. The 
transfer of the high-energy electrons along the electron transport chain results in the 
pumping of H+ ions across the inner membrane, creating an electrochemical gradient (also 
named membrane potential, m) that provides the energy required to drive the synthesis 
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of ATP thanks to a fifth complex called F0F1 ATP synthase. The latter consists of a H+ ion 
channel (F0) connected to a catalytic subunit (F1). The energy provided by the flux of H+ ions 
through F0 is used to drive ATP synthesis from ADP and Pi by F1 (Figure 2). The 
electrochemical gradient determines the coupling between the oxidative and the 
phosphorylative reactions. It is named oxidative phosphorylation (OXPHOS). 
 
Fig. 2. Main organization of mitochondrial oxidative and phosphorylative pathways. 
TCA cycle, tricarboxylic cycle; Complex I, NADH-CoQ oxidoreductase; Complex II, 
succinate dehydrogenase; Complex III, CoQ-cytochrome c oxidoreductase; Complex IV, 
cytochrome c oxidase; Q, coenzyme Q or ubiquinone; Cyt c, cytochrome c; ANT, adenine 
nucleotide translocase, ANT; mtCK, creatine kinase. This figure is derived from Wikipedia. 
Mitochondrial membrane potential is a key indicator of cellular viability. As demonstrated 
by Peter Mitchell (1961), it is the driving force behind ATP production. It also governs ROS 
production, mitochondrial calcium storage, opening of mitochondrial permeability 
transition pores (mPTP) and mitochondrial-apoptotic programmed cell death (reviews in 
Casteilla et al., 2001; Hand & Menze, 2008). Mitochondrial ATP production has to strictly 
match cellular needs. It is tightly controlled by different factors. The ATP/ADP-Pi ratio, 
through a mitochondrial ADP sensing which is still not fully understood (Wilson et al., 
1977), the NAD+/NADH-H+ ratio and local oxygen pressure chance. The transfers of ATP, 
ADP and Pi between the cytosol and the mitochondrial matrix involve ATP/ADP carriers 
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(adenine nucleotide translocase, ANT). The high-energy phosphate group of ATP may be 
also transferred to creatine to yield phosphocreatine. This reaction is catalyzed by the 
mitochondrial isoform of creatine kinase (mtCK), which is located in the mitochondrial 
intermembrane space. The dynamic of the phosphate group transfer between ATP and 
creatine and the transport of these metabolites between cytosol and mitochondrial 
intermembrane space, differs between contractile fiber types. This is due to differential 
coupling between mtCK, ANT and porin (voltage-dependent anion channel, VDAC) which 
determines the flux of ADP entrance within the mitochondrial matrix (Saks et al., 1994). 
Unlike glycolytic fibers (type IIb) for which mitochondrial respiration is regulated by 
cytosolic ADP, mitochondrial respiration of oxidative fibers (type I) is more controlled by 
the ratio between creatine and phosphocreatine than by ADP (Zoll et al., 2003). The oxydo-
glycolytic fibers (type IIa) present an intermediate situation. 
Except in Asian Indians, consistent decrease in muscle mitochondrial ATP production has 
been reported in insulin resistance in obesity and type 2 diabetes (Petersen et al., 2004, 2005; 
Szendroedi et al., 2007; Chanseaume et al., 2010). By contrast, the theory linking insulin 
resistance to decreased mitochondrial oxidative capacity is more challenged. It has been 
supported by several cross-sectional studies in obese insulin-resistant and type 2 diabetic 
patients compared to healthy individuals (Howald et al., 1985; Kelley et al., 2002; Pertersen 
et al., 2004; Ritov et al., 2005, 2010). These observational studies are reviewed in table 1. By 
contrast, recent studies (Petersen et al., 2005; Chanseaume et al., 2010) and clinical trials that 
involve interventions (weight loss, physical activity) altering insulin sensitivity (Brons et al., 
2008; Toledo et al., 2008) demonstrated a dissociation between insulin resistance and 
mitochondrial functioning in skeletal muscle. Part of the discrepancy may be due to bias 
induced by confounding factors, such as physical activity. Indeed when the latter factor is 
rigorously taken into account, mitochondrial oxidative capacity is similar between lean and 
obese-insulin resistant volunteers (Chanseaume et al., 2010). However, genetic and/or 
epigenetic predisposition have also to be taken into account (Petersen et al., 2004, 2005; 
Morino et al., 2005; Befroy et al., 2007; Nair et al., 2008). 
2.2 Mitochondrial fatty acid oxidation and cellular meanings 
Mitochondria are the principal site of long-chain fatty acid (LCFA) oxidation for cellular 
energy production. A defect in this process may trigger the accumulation of toxic lipid 
metabolites in skeletal muscle. Mitochondrial LCFA oxidation is tightly regulated by the 
enzyme carnitine palmitoyltransferase 1 (CPT1), which is situated in the outer 
mitochondrial membrane and regulates the entry of acyl-CoAs into mitochondria. Malonyl-
CoA, the first metabolic intermediate of lipogenesis produced by the enzyme acetyl-CoA 
carboxylase, is the physiological allosteric inhibitor of CPT1 (McGarry & Brown, 1997). This 
malonyl-CoA/CPT1 partnership is considered as a “fuel sensor” whose role is to regulate 
the rate of LCFA oxidation according to the relative disposal of LCFA and glucose within 
the cell. When circulating lipids increase, whereas glucose availability decreases (such as 
during starvation), lipids are oxidized in mitochondria at the expense of glucose 
(Rasmussen & Wolfe, 1999). When mitochondrial LCFA oxidative capacity becomes limited, 
excess LCFAs taken up by the cell are initially redirected towards storage in the form of 
triacylglycerols (TAG). For these reasons, new concept has emerged pointing out muscle 
mitochondrial dysfunction as the leading cause for TAG accumulation in obesity and insulin 
resistance (Petersen & Shulman, 2006). 
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Abdul-Ghani et al., 2009? in obese, = in type-2 diabeticObese and type-2 diabetic
Chanseaume et al., 2010?Obese and insulin resistant*
ROS production
Schrauwen-Hinderling
et al., 2007?Type-2 diabetic
Brons et al., 2008=Insulin resistant with predisposition
P-creatine synthesis
Nair et al., 2008=Type-2 diabetic
Szendroedi et al., 2007?Type-2 diabetic
Abdul-Ghani et al., 2009?Obese and type-2 diabetic
Chanseaume et al., 2010?Obese and insulin resistant*
Petersen et al., 2005?Insulin resistant with family predisposition
Petersen et al., 2004?Insulin resistant with family predisposition
ATP synthesis
Nair et al., 2008= Citrate synthaseType-2 diabetic
Ortenblad et al., 2005? Citrate synthaseType-2 diabetic
Boushel et al., 2007? Citrate synthaseType-2 diabetic
Kelley et al., 2002? Citrate synthase, complexe 1Obese and type-2 diabetic
He et al., 2001? Complexe 2Obese and type-2 diabetic
Ritov et al., 2005? Complexe 2Obese and type-2 diabetic
Chanseaume et al., 2010= Citrate synthase, COXObese and insulin resistant*
Holloway et al., 2007? CPT1, ßHAD, COXObese
Kim et al., 2000? CPT1, ßHAD, citrate synthaseObese
Heilbronn et al., 2007? Citrate synthaseInsulin resistant
Maximal enzyme activity
Befroy et al., 2007? acetyl-CoA oxidationInsulin resistant with family predisposition
Kim et al., 2000? LCFA oxidationObese
Substrates oxidation
Nair et al., 2008= PGC-1a/ß, NRF1, OXPHOSType-2 diabetic
Debard et al., 2004? PGC-1aType-2 diabetic
Mootha et al., 2003? PGC-1a/ß, OXPHOSType-2 diabetic
Patti et al., 2003? PGC-1a/ß, NRF1, OXPHOSType-2 diabetic and insulin resistant with predisposition
Chanseaume et al., 2010= PGC-1a/ß, NRF1, OXPHOSObese and insulin resistant*
Brons et al., 2008= PGC-1a , OXPHOSInsulin resistant with family predisposition
Heilbronn et al., 2007? PGC-1a , complexes 1-3-4Insulin resistant with family predisposition
Biogenesis signalling pathway
Ritov et al., 2005? sizeType-2 diabetic
Kelley et al., 2002? size, areaObese and type-2 diabetic
Morphology
Ashmann et al., 2006=Type-2 diabetic
Nair et al., 2008=Type-2 diabetic
Boushel et al., 2007?Type-2 diabetic
Ritov et al., 2005?Obese and type-2 diabetic
Chanseaume et al., 2010=Obese and insulin resistant*
Holloway et al., 2007?Obese
Morino et al., 2005?Insulin resistant with family predisposition
Mitochondrial content
ReferencesResultsPopulation studiedMeasured parameters
 
Table 1. Alterations in mitochondrial structure, content and functioning reported in skeletal 
muscle of insulin resistant, obese and/or type-2 diabetic patients. * all volunteers were 
similarly sedentary 
Cellular TAG buffering capacity in lean tissues such as skeletal muscle, is limited and 
rapidly flooded, especially for saturated LCFAs such as palmitate which are poorly 
incorporated into TAG (garcia-Martinez et al., 2005). In these conditions, excess LCFAs may 
enter alternative non-oxidative pathways that result in the production and accumulation of 
toxic lipid metabolites, such as diacylglycerols (DAG), acyl-CoAs or ceramides. These LCFA 
derivatives have been demonstrated to be deleterious for cell functioning since they are able 
to modulate activity of protein kinases (Shulman, 2000; Hegarty et al., 2003) which 
ultimately trigger insulin resistance (Shulman, 2000; Chavez et al., 2005), mitochondrial 
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dysfunction (Coll et al., 2006), oxidative stress (Montuschi et al., 2004) and apoptosis (Slawik 
& Vidal-Puig, 2006). Whereas mechanisms linking those LCFA metabolites to insulin 
resistance have raised large consensus, the involvement of mitochondrial LCFA oxidative 
capacity in the regulation of their synthesis rates is still controversial (Rimbert et al., 2004, 
2009). These arguments suggest that more complex interactions exist between LCFA 
availability and cell metabolism, and determine the intracellular fates of LCFAs (for review 
Kewalramani et al., 2010). 
2.3 Mitochondrial production of reactive oxygen species and cell consequences 
During the electron transfer through the respiratory chain, a small percentage of electrons 
may prematurely reduce oxygen, forming reactive oxygen species (ROS) such as superoxide 
anion radicals (O2
-).  It was demonstrated that the main sites of ROS production are located 
at complexes I and III, the iron-sulphur centers of complex I being potentially the most 
important ROS generators (Barja, 1999). ROS are generated either from “normal” electron 
transfer after oxidation of substrates of complex I and complex II, but also from “reversed” 
electron transfer from complex II towards complex I (Liu et al., 2002). The latter situation is 
suggested to be the most physiologically relevant ROS production in mammals (Miwa & 
Brand, 2003). Recent work from Seifert et al. (2010) showed that LCFA β-oxidation is 
associated with enhanced ROS production, through a mechanism involving complex III, the 
electron transfer flavoprotein (ETF) and ETF-oxidoreductase.  
As reviewed by Murphy (2009), the rate of ROS production is mainly determined by the 
membrane potential, the ratio between NADH and NAD+, the ratio between CoQH2 and 
CoQ and the local O2 concentration. It is well established that there is a strong positive 
correlation between membrane potential and ROS production. Small increase in membrane 
potential has been associated to a large stimulation of ROS production (Korshunov et al., 
1997). Similarly, a small decrease in membrane potential deeply reduces ROS production 
(Votyakova & Reynolds, 2001). Therefore mild uncoupling resulting from a small decrease 
in membrane potential is considered as a natural antioxidant process (Seifert et al., 2010; 
Skulachev, 1997). However, not all sites of ROS production are sensitive to membrane 
potential. Indeed, Seifert et al. (2010) found that the ROS produced during LCFA β-
oxidation and involving complex III, ETF and ETF-oxidoreductase, was relatively 
insensitive to membrane potential changes. In addition, Miwa and Brand reported that the 
ROS produced at the cytosolic side of complex I through glycerol-3-phosphate 
dehydrogenase, which donates electrons to the electron carrier Q, is insensitive to 
membrane potential (2003). By contrast, ROS production from complex I following reverse 
electron flow is highly sensitive to membrane potential. Mild uncoupling is based on a 
proton leak across the inner membrane. It is mediated by thyroid hormones, LCFAs, 
complex IV slipping but most importantly by the activity of the uncoupling proteins UCP2 
and UCP3, although molecular mechanism are still not well understood (for review see 
Murphy, 2009; Schrauwen & Hesselink, 2002; Bezaire et al., 2007). Whereas overexpression 
of UCP in skeletal muscle has been shown to prevent diet-induced obesity and insulin 
resistance in mice (Li et al., 2000), their specific involvement in mitochondrial functioning 
and muscle metabolism in obesity and type 2 diabetes is still under debate in humans 
(Krook et al., 1998; Bao et al., 1998; Samec et al., 1999). 
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Spontaneously or by the action of superoxide dismutase (SOD), O2
- dismutates into 
hydrogen peroxide H2O2, which is more stable and can diffuse through biological 
membranes. H2O2 has been shown to inhibit TCA cycle oxidative enzymes (alpha-
ketoglutarate dehydrogenase, succinate dehydrogenase, aconitase) and complex II (Moser et 
al., 2009; Nulton-Persson & Szweda, 2001). It is an important signal molecule, regulating 
major redox signalling pathways (for review see Leloup et al., 2011). It can also react to form 
hydroxyl radical or peroxynitrite, which are both highly damaging. In that context, 
oxidative stress can occur due to the accumulation of oxidative damages within DNA, 
protein and lipid components of the organelle. This may contribute to the decline in 
mitochondrial function and lead in turn to enhanced ROS generation. This vicious circle has 
been involved in many pathologies and the aging process. It is however questioned in the 
aetiology of insulin resistance in obesity and type 2 diabetes because reduced mitochondrial 
ROS production has been reported in those latter situations (Abdul-Ghani et al., 2009; 
Chanseaume & Morio, 2009). Because mitochondrial dysfunction in type 2 diabetes has been 
related to oxidative stress (Bonnard et al., 2008), other cellular sites of ROS production are 
potentially involved. 
2.4 Mitochondrial calcium storage and cellular consequences 
Mitochondrial calcium uptake has been first described in the early 1960s (Deluca & 
Engstrom, 1961; Vasington & Murphy, 1962). Since then it has been recognized that 
mitochondria are able to store amount of calcium bound to phosphate within their matrix 
large (review in Nicholls & Chalmers, 2004). Differential regulation of mitochondrial Ca2+ 
uptake and release are presented by Hoppe (2010). Calcium taken up by the mitochondria 
regulates mitochondrial functioning in response to a variety of extracellular stimuli 
(Jouaville et al., 1999; Territo et al., 2000). It activates three dehydrogenases of the TCA 
cycle, pyruvate dehydrogenase, isocitrate dehydrogenase, and -keto glutarate 
dehydrogenase (63). It may also regulate the ETC, the F0F1ATP synthase and ANT 
(McCormack et al., 1990). This induces an increased substrate uptake by mitochondria, 
enhanced mitochondrial NADH/NAD+ ratio and increased ATP production. The high 
capacity to accumulate calcium confer to mitochondria a key role in the regulation of 
intracellular calcium signalling (Gunter KK & Gunter TE, 1994; Rizzuto et al., 1998), which 
includes regulation of gene expression (including those involved in mitochondrial 
biogenesis and glucose uptake), cell functioning, control of protein trafficking between 
compartments, and processes linked to the suffering and eventual demise of cells (for 
review see Lukyanenko et al., 2009). 
2.5 Mitochondrial involvement in cell apoptosis  
Mitochondria are closely involved in the induction of apoptosis. Indeed, the intermembrane 
space contains several pro-apoptotic proteins which can lead to cell death upon release into 
the cytosol. Mitochondrial dysfunctions precede and are required for the initiation of the 
mitochondrial apoptosis pathway (for review see Marzetti et al., 2010). As previously 
mentioned, subsarcolemmal and intermyofibrillar mitochondria display different 
susceptibility towards apoptotic stimuli (Adhihetty et al., 2005). Mitochondria may therefore 
be involved in the pathogenesis of muscle atrophy, in obesity and type 2 diabetes or in 
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response to short-term immobilisation in ageing individuals (Kim  et al., 2010; Magne et al., 
2011). 
3. Transcriptional regulation of mitochondrial oxidative capacity – interaction 
with fusion-fission dynamics 
A number of transcriptional modulators have been implicated in the regulation of muscle 
mitochondrial biogenesis and OXPHOS activity (figure 3, see also for review Puigserver & 
Spiegelman, 2003; Chanseaume & Morio, 2009). They include PPAR gamma coactivator 1 
alpha (PGC-1), in cooperation with several factors such as PGC-1β, the peroxisome 
proliferator-activated receptors (PPAR), the estrogen-related receptor- (ERR), the nuclear 
respiratory factors 1 and 2 (NRF-1 and NRF-2) (Fredenrich & Grimaldi, 2004; Patti et al., 
2003; Sparks et al., 2005; Tanaka et al., 2003), or the specificity protein 1 (Sp1), an ubiquitous 
transcription factor known to regulate the constitutive expression of oxidative OXPHOS 
genes (Zaid et al., 1999). Sp1 can function as both a positive (e.g. cytochrome c1 and 
mitochondrial transcription factor A, TFAM) and a negative (e.g. ANT2 and F1-ATPase beta 
subunit) regulator of transcription (Yang et al., 2001). 
PPAR and PPAR are involved in the regulation of mitochondrial LCFA oxidative 
capacity. When bound to their ligands (e.g. LCFA), PPARs form a heterodimeric complex 
with the retinoid X receptor (RXR) to regulate gene transcription involved in LCFA 
metabolism. Muscle-specific overexpression of PPAR in mice was shown to increase 
oxidative enzyme activities such as citrate synthase or -hydroxyacyl-CoA dehydrogenase, 
and to enhance expression of genes implicated in fatty acid catabolism (Luquet et al., 2003). 
PGC-1 and PGC-1β, but most importantly PGC-1, are master modulators of gene 
expression in skeletal muscle (Moyes, 2003). PGC-1β has been shown to drive the formation 
of highly oxidative fibers containing type IIX myosin heavy chain (Arany et al., 2007). By 
contrast, PGC-1 was found to drive the formation of oxidative type I fibres (Lin et al., 
2002). In muscle cells, overexpression of PGC-1 was shown to induce the gene expression 
of NRF-1, NRF-2, TFAM and to activate the expression of genes involved in mitochondrial 
oxidative capacity (Chabi et al., 2005). PGC-1 gene expression is potently regulated by 
CREB (cAMP response element-binding protein) binding protein (TORC) 1, a coactivator of 
CREB (Wu et al., 2006), and by the sirtuin SIRT1 (Amat et al., 2009). Its activity is increased 
when phosphorylated by p38 stress-activated MAPK (Puigserver et al., 2001) and when 
deacylated by SIRT1 (Lagouge et al., 2006). Coactivation of ERR and PPARs by PGC-1 
and PGC-1β has been proposed as the major regulatory pathway involved in the control of 
mitochondrial oxidative capacity (Puigserver & Spiegelman, 2003; Arany et al., 2007; 
Soriano et al., 2006). For these reasons, alterations in PGC-1, and to a lesser extent PGC-1β, 
activity are considered the primary contributors to decreased mitochondrial oxidative 
capacity in metabolic disorders. Potential intrinsic mechanisms responsible of alterations in 
mitochondrial biogenesis are reviewed in Chanseaume et al. (2009). 
Finally and complementary to mitochondrial biogenesis, recent evidences have 
demonstrated that the dynamics of mitochondrial network is strongly involved in the 
control of mitochondrial functioning. It is determined by the balance between fusion and 
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fission events which are govern by mitochondrial proteins such as mitofusin 1 and 2 (Mnf1, 
Mnf2) and OPA1 for fusion, and dynamin-related protein (DRP1) for fission. Importantly, 
Mfn2, which gene expression is regulated by PGC-1 and PGC-1β (Pich et al., 2005; Soriano 
et al., 2006), stimulates respiration, substrate oxidation and OXPHOS subunits expression 
(Pich et al., 2005). Zorzano et al. (2009) therefore hypothesized that these mitochondrial 
dynamics proteins play a key role in mitochondrial dysfunction in obesity or in type 2 
diabetes and may participate in the development of insulin resistance. This concept is 
supported by recent studies in muscle (Zorzano et al., 2009) and neurons (Edwards et al., 
2010). 
Biogenesis
PPAR , 
Fatty acid oxidation OXPHOS activity
NRF-1 / NRF-2
PGC-1
DNA
transcription
Muscle mitochondrial OXPHOS activity
Co-activators
Transcription factors
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(MCAD), Carnitine palmitoyl transferase 1
(CPT-1), Hydroxyacyl-CoA dehydrogenase (HAD) 
Cytochrome oxidase 4 (COX IV), 
Cytochrome c, ATP synthase ,
Citrate synthase (CS)
Mitochondrial transcription 
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Sp1
PGC-1ß
Fusion-Fission
Mitofusin 2 (Mfn2)
ERR
 
Fig. 3. Major coactivators and transcription factors involved in the regulation of muscle 
mitochondrial oxidative and phosphorylation (OXPHOS) activity. Non exhaustive key 
genes, whose expression is regulated by the transcription factors, are given for example. 
4. Measurement of muscle mitochondrial OXPHOS activity on muscle biopsy 
samples 
Changes in mitochondrial functioning can be assessed using a battery of biochemical 
analyses that can often be applied to whole tissue, cells or isolated organelles. These 
techniques are essential for elucidating intrinsic mechanisms responsible for mitochondrial 
dysfunctions. However most frequently, they inform about the maximal activity of key 
enzymes or pathways. In addition, they are limited to the conditions used for the 
measurements, for example the substrates used to feed the ETC. Therefore, care should be 
always taken in extrapolating ex vivo observations to the in vivo situations and 
generalization should be avoided. 
4.1 Samples preparation 
Because unfreezing muscle samples brakes mitochondrial structure and alters their 
functionality, most measurements have to be performed on fresh samples. It is possible to 
maintain the tissue intact during several hours by using a preservation solution at 4°C  until 
mitochondrial isolation or skinned fiber preparation. Depending on the information 
required, mitochondrial functioning can be assessed either on isolated organelles or on 
whole tissue. The latter solution means that one works on tissue homogenates or using the 
skinned fiber technique. Isolated mitochondria can be obtained by differential centrifugation 
www.intechopen.com
 
Muscle Biopsy 
 
94
from at least 80mg of homogenized muscles (Palmer et al., 1977; Capel et al., 2004; 
supplementary material). This approach is dedicated to the exploration of the organelle 
intrinsic functioning. Although contaminated by lysosomes, peroxisomes, tubular Golgi 
membranes, and small amounts of endoplasmic reticulum, the obtained fraction is suitable 
for respiratory studies (96). Further purification is possible, for example, with Percoll 
gradients as described by Mickelson et al. (1980) and Graham (2001). Mitochondrial integrity 
can be monitored by measuring citrate synthase activity before and after freeze–thaw 
membrane disruption and Triton X-100 addition (Stump et al., 2003). Similarly, 
mitochondrial purity can be assessed by assessing marker enzymes for lysosomes (β-
galactosidase) and peroxisomes (catalase) as discussed by Graham (2001). 
By contrast, although evaluated ex-vivo, permeabilized fibers take into account both the 
intrinsic functioning of mitochondria and the cellular content in mitochondria. Of note, 
skinned fibers require less muscle sample than the isolation procedure. Fifteen to 20 mg of 
fresh muscle sample is sufficient for one preparation of saponin-skinned muscle fibers. 
Briefly as described by Saks et al. (1998), fiber bundles are mechanically separated with 
tongs and permeabilized with saponin on ice. Bundles are then washed to remove ADP, 
phosphocreatine, soluble enzymes and metabolites. All steps are critical for obtaining clean 
skinned fibers for accurately measuring mitochondrial OXPHOS activity and coupling. The 
time of incubation with saponin depends on the cell type and the animal model. This 
technique requires therefore a well-trained investigator to assure accurate and repeatable 
measurements. Novices should follow at the beginning the association between the degree 
of mechanical separation, time of incubation with saponin and percentage of cells 
permeabilized and/or respirometric responses. Overpermeabilization should be avoided. 
The degree of permeabilization can be checked using toluidine blue under optic microscopy. 
Mitochondrial outer membrane integrity can be also verified during respirometry 
measurements by checking that addition of cytochrome c had no effect on oxygen 
consumption.  
4.2 Evaluation of mitochondrial density 
Mitochondrial density, as well as location, shape and structural integrity, can be reliably 
assessed using transmission electron microscopy. For that purpose, muscle samples are 
dissected free of adipose and connective tissue, cut into small pieces (1x1x2mm) and fixed.  
Transverse sections of 8µm are cut using a cryostat and mounted on slides. Images of 10 
random and independent transverse sections of muscle fibers at 36,000 X must be 
considered. Mitochondrial cross-sectional area (size) and mitochondrial volume density (the 
fraction of cell volume occupied by mitochondria) are measured by digital imaging 
morphometry and stereological principles of point sampling, in a blind fashion (Weibel, 
1979; Gundersen et al., 1988).  
Maximal activity of citrate synthase has been often used as an index of mitochondrial 
density. This measure is performed on whole tissue homogenates. However, citrate 
synthase activity can be altered in some physiological situations independently of changes 
in mitochondrial density. For example, it is well known that aging is associated to a decrease 
in citrate synthase activity whereas other mitochondrial oxidative enzyme activities are 
unaltered (Rimbert et al., 2004). 
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Recently the number of mitochondrial DNA (mtDNA) copy has been considered to reflect 
mitochondrial content (Wiesner et al., 1992; Barrientos, 2002), the ratio between mtDNA and 
nuclear DNA has been proposed as a reliable index of mitochondrial density. For that 
purpose, mitochondrial and nuclear DNAs are extracted during the standard procedure of 
RNA extraction as described in Chanseaume et al. (2010) and in supplementary material. 
Purified DNA is ready for  quantitative real-time PCR analysis of nuclear and mitochondrial 
DNA content using primer pairs specific for nuclear (β-actin or myogenin promoter) and 
mitochondrial (NADH dehydrogenase 1 (ND1), ND2, cytochrome B or cytochrome c 
oxidase 1 (COX1)) genes (Stump et al., 2003; Petersen et al., 2005; Chanseaume et al., 2010). 
4.3 Assessment of maximal activity of key oxidative enzymes 
This technique allows the use of frozen samples, either whole tissues, homogenates or 
isolated organelles. Frozen samples should be kept at -80°C for better preservation of the 
enzymes integrity. It assesses the maximal activity of the enzyme catalytic site. For that 
purpose, optimal concentrations in substrates are used to stimulate the enzyme activity. 
Catalytic activity is determined mostly using spectrophotometry on sample homogenates 
prepared in sucrose, EDTA Tris-HCl buffer (supplementary material)). For example, complex I 
activity is assessed measuring NADH oxidation at 340nm. Similarly, complex IV activity is 
performed at 550nm following the oxidation of reduced cytochrome c. Enzyme activities are 
often expressed per mg of mitochondrial protein but a most relevant normalisation should be 
citrate synthase activity or, because of the reason exposed in the previous paragraph, mtDNA 
content. Methods for measuring the separate activity of all ETC complexes as well as citrate 
synthase activity are extensively described by Barrientos (2002). 
Finally, one can also consider the maximal activity of β-hydroxyacyl-CoA dehydrogenase as 
a fair index of the beta-oxidation pathway. The assay has been established by Bass et al. 
(1969). Its principle is based on the disappearance of NADH following reduction of 
acetoacetyl-CoA to ß-Hydroxybutyryl-CoA (supplementary material). 
4.4 Measurement of fatty acid oxidative capacity 
Whole muscle LCFA oxidative capacity can be easily determined on fresh muscle 
homogenates. This technique described by Veerkamp et al. (1983), informs on the maximal 
ability of muscle tissue to oxidize a specific LCFA. Using two distinct preparations, one can 
separate peroxisomal from mitochondrial beta-oxidation activities. Of note, our personnal 
data repeatedly showed that the peroxisomal contribution to whole tissue LCFA oxidative 
capacity averages 10-14%, in humans as well as in rodents. 
This technique uses a radiolabelled [1 or U-14C] fatty acid (such as oleate or palmitate for the 
most commons) bound to albumin at the ratio 4.5:1 (Morio et al., 2001; Rimbert et al., 2004; 
Tardy et al., 2008). A detailed procedure is provided in supplementary materials. Briefly, total 
LCFA oxidation is measured using sealed vials containing an aliquot of muscle homogenate in 
the presence of ATP, NAD+, coenzyme A, L-carnitine, L-malate and cytochrome c. 
Peroxisomal LCFA oxidation is determined in the presence of mitochondrial oxidation 
inhibitors (rotenone and antimycin A), but in the absence of  L-carnitine and L-malate . 
CPT-1 is the key enzyme regulating muscle fatty acid oxidative capacity. It is allosterically 
inhibited by malonyl-CoA (Rasmussen & Wolfe, 1999). The method measures the amount of 
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palmitoyl-carnitine produced from palmitoyl-CoA and carnitine as described by Kim et al. 
(2000) and is presented in supplementary materials. CPT-1 activity is measured on freshly 
isolated mitochondria. It allows assessment of maximal CPT-1 activity as well as its 
sensitivity to malonyl-CoA inhibition (IC50). Although rarely used, CPT-1 maximal activity 
can be also assessed from fresh whole muscle homogenates using modification of the above 
mentioned method ( Rimbert et al., 2004). Alternatively, the affinity of mitochondria for 
palmitoylcarnitine could be assessed using isolated muscle fibers (Ponsot et al., 2005). 
4.5 Measurement of mitochondrial respiration 
Table 2 summarizes the main substrates used to assess mitochondrial oxidative capacity on 
isolated organelles or skinned fibers. It also presents the inhibitors required for additional 
investigation of mitochondrial intrinsic functioning and for measuring state 4 respiration 
rate. Isolated mitochondria or skinned fiber respiration rates are usually measured at 25°C 
using an oxygraph system. Higher temperatures, e.g. 30 or 37°C, can be used. This enhances 
the respiratory rate. Respiration is assayed on 0.25 mg/mL of mitochondrial proteins or 0.5-
1.5 mg dried fibers in a specific buffer provided in supplementary materials. 
FCCP (1µM)
Valinomycin (3µM)
Uncouplers
Atractyloside (60µM)
Carboxyatractyloside
(250µM)
Bongkrekate (1.5µM)
ANT
Oligomycin B (10µM)Complex V
KCN (0.3mM)
Azide (10 mM)
Ascorbate/TMPD (5mM/1mM)Complex IV
Antimycin A (10µM)
Stigmatellin (6.6 µM)
Duroquinol (0.6mM)
Glycerol-3Phosphate (5mM)
Complex III
Malonate (10mM)
TTFA (1mM)
Succinate* (5mM)Complex II
Rotenone (2.4µM)
DPI (0.4mM)
Amytal (2mM)
Glutamate/L-Malate (5mM/2mM) Pyruvate/L-
Malate (5mM/2mM)
-ketoglutarate (10mM)
Complex I
Octanoyl-L-carnitine/L-Malate (100µM/1mM)
Palmitoyl-L-carnitine/L-Malate (55µM/1mM)
ß-oxidation
Propionyl-L-carnitine
Pyruvate/Palmitoyl-L-carnitine/-ketoglutarate/L-
malate (1mM/5µM/10mM/1mM)
TCA cycle
inhibitorssubstrates
 
Table 2. Substrates, inhibitors and uncouplers used in the polarographic experiments. 
Concentrations within brackets are indicative. * used in the presence of rotenone (2 µM); DPI, 
diphenyliodonium chloride; TTFA, Thenoyltrifluoacetone; TMPD, N,N,N’,N’-tetramethyl-p-
phenylenediamine; KCN, potassium cyanide; FCCP, carbonyl cyanide p-
(trifluoromethoxyl)phenylhydrazone. 
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State 2 (non-phosphorylating) respiration is measured in the presence of respiratory 
substrates without ADP. State 3 (phosphorylated) respiration is measured after the addition 
of of ADP, saturating concentration leading to maximal ADP-stimulated respiration being 1 
mM (Gueguen et al., 2005). A replicate experiment can be done to evaluate uncoupled 
respiratory rate in the presence of an uncoupler such as carbonylcyanide p-
(trifluoromethoxy)phenylhydrazone (FCCP). State 4 respiration is assayed after addition of 
oligomycin B, an inhibitor of ATP synthase, or after addition of atractyloside, a potent 
inhibitor of ANT. This measure validates the quality of fiber preparation (notably complete 
removal of free ADP during washing) if respiration returns to state 2. However, inhibiting 
ANT may improve the OXPHOS coupling since ANT may be responsible for basal and 
LCFA-induced uncoupling ( Di Paola & Lorusso, 2006). Respiratory control rate is evaluated 
by dividing state 3 by state 4 rates. Respiration rates are expressed as natom (nat) 
O/min/µg protein for isolated mitochondria or natom (nat) O/min/mg dried (24 h at 
110°C) fibers  for skinned fibers. 
When differential regulation of respiration by ADP and mitochondrial kinases (creatine 
kinase, AK2) is of interest, titration protocols with increasing concentration in ADP (from 0.1 
to 1 mM) should be performed in the presence or not of 20 mM creatine (creatine kinase 
activation), or 10 mM glucose (hexokinase activation), 1 mM AMP (AK2 activation), 10 µM 
Ap5A (AK2 inhibition) (Gueguen et al., 2005). The functional coupling of miCK to energy 
production could be determined, calculating the affinity for ADP using a combined protocol 
on permeabilized fibers (N'Guessan et al., 2004). 
4.6 Measurement of mitochondrial ATP production 
ATP synthase (ATPase) activity is assayed on freshly isolated mitochondria. Maximal activity 
is measured spectrophotometrically by monitoring the increase in absorbance at 340 nm 
using a NADP-linked ADP-regenerating system. Mitochondria are added to the reaction 
buffer in the presence of glucose, AMP, NADP, ADP, hexokinase, and glucose-6-P 
dehydrogenase (see supplementary materials) and the reaction is followed at room 
temperature (Rustin et al., 1994). Similarly, it can also be assessed using a coupled assay 
between lactate dehydrogenase and pyruvate kinase, NADH reduction being checked at 340 
nm (Rustin et al., 1994). 
ATP production can be directly measured using bioluminescence kit assay by incubating 
isolated mitochondria with various substrates of the ETC (Table 2). Blank tubes are used for 
measuring background and all reactions for a given sample are monitored simultaneously 
and calibrated with addition of an ATP standard. Mitochondrial ATP production is 
calculated from the area under the curve (Wibom & Hultman, 1990). 
Finally, mitochondrial ATP production can be measured kinetically in parallel with 
respiration (on isolated mitochondria or permeabilized fibers) as described by Ouhabi et al. 
(1998). After ADP is added, five 10µl samples are taken every 15 sec in the oxygraph 
chamber, and frozen in 100µl DMSO before ATP is assayed using a bioluminescence assay 
kit. ATP production rate is expressed as nmol/min/mg dried fibers. ATP/O is calculated to 
evaluate coupling of ATP production to ADP-stimulated oxygen consumption (state 3 in 
nmol O2/min/mg) (Chanseaume et al., 2010). 
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4.7 Measurement of mitochondrial ROS production 
Using similar incubation conditions than described for respiration or ATP assays, 
superoxide anion (O2
-) can be assessed on isolated mitochondria using the 
chemiluminescent probes 2-methyl-6-p methoxyphenylethynylimidazopyazinone (MPEC) 
(Nakai et al., 2004) or lucigenin (Bis-N-methylacridinium) (Li et al., 1999). Fluorescent 
sensitive probes such as hydroethidine, especially MitoSOXTM Red which targets the 
mitochondrial matrix, can also be used. Isolated permeabilized fibers were recently used for 
O2
- generation measurement using the triphenylphosphonium Hydroethidine (TTP-HE) 
reporter (Xu et al., 2010). Signals were analyzed by micellar electrokinetic capillary 
chromatography coupled to fluorescence detection. 
O2
- rapidly dismutates into H2O2 in the presence of mitochondrial SOD which considerably 
reduce its matrix level. Then the quantification of the more stable H2O2 can be assessed using 
luminol chemiluminescence (Li et al., 1999). H2O2 can be also measured using non-fluorescent 
dyes that become fluorescent upon enzymatic oxidation by H2O2 in the presence of 
horseradish peroxidase. The most commonly used dyes are homovanilic acid (Ruch et al., 
1983), 2',7'-dichlorfluorescein-diacetate (DCFH-DA) or Amplex® Red (Chen et al., 2003). 
Kinetic or global approaches are both adequate for calculating the rate of mitochondrial ROS 
production. Standard curve is obtained by adding known amounts of H2O2 to assay medium 
in the presence of the reactants. It is critical to quantify background fluorescence, in the 
absence of mitochondria. Net fluorescence is then calculated minus background and H2O2 
production is expressed in pmol/mg of protein/min. The heterogeneity of mitochondrial 
alteration during metabolic disorders could be studied on permeabilized fibers, characterizing 
the specificity of H2O2 production depending on myofiber type (Anderson et al., 2006). If 
oxygen consumption and ROS production were determined in similar experimental conditions 
on isolated mitochondria or permeabilized fibers, the free radical leak can be calculated as an 
indicator of the fraction of electron reducing oxygen to O2
- (Sanz et al., 2005). It has been 
shown that this leakage was higher in glycolytic compared to oxidative fibers (Anderson et al., 
2006). More recently, new methods were developed to analyze local change in ROS generation 
on individual isolated fibers. Hence, ROS production could be analyzed by confocal imaging 
(Shkryl et al., 2009) or real time fluorescence microscopy (Palomero et al., 2008). Although 
more reliable than O2
- quantification, the detection of H2O2 as an index of O2- production has 
also its limits, i.e., the reaction of O2
- with other molecules (such as NO), the removal by 
matrix peroxidase and contamination by H2O2 produce within the intermembrane space (see 
(Murphy, 2009) as a more detailed review on this topic). 
4.8 Additional measurement of mitochondrial functionality 
Mitochondrial membrane potential can be determined simultaneously with oxygen consumption 
using the potential-dependent triphenylmethylphosphonium cation (TPMP+) probe as 
described by Kamo et al. (1979). Development of fluorescent probes sensitive to mitochondrial 
membrane potential has facilitated the investigation on isolated organelles as well as cells. The 
most commonly used dyes are rhodamine 123, its derivatives tetramethylrhodamine methyl 
and ethyl esters (TMRM and TMRE), 3,3'-dihexyloxacarbocyanine,iodide (DiOC6(3)) and 
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benzimidazolcarbocyanine iodide (JC-1). The latter has 
been proposed as the most reliable probe (Salvioli et al., 1997). Results are usually compared 
with those obtained in the presence of a mitochondrial uncoupler, such as FCCP, to attain 
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maximum depolarization. Membrane potential could also be determined using isolated 
permeabilized fibers in a multiwell plate (Xu et al., 2010). 
Calcium retention capacity of mitochondria and sensitivity of the permeability transition pore is 
evaluated on isolated mitochondria using the same incubation buffer and substrates than for 
respiration, except that 1 µM Calcium GreenTM-5N is added (Fontaine et al., 1998). Pulses of 
10 µM Ca2+ are added every minute until pore opening. Specificity of mitochondrial pore 
opening is assessed by adding cyclosporin A. Comparison between fiber types could be 
done in a similar approach using permeabilized fibers (Picard et al., 2008). 
4.9 Evaluation of mitochondrial biogenesis and fusion-fission dynamics 
Supported by steadily increasing literature data, changes in mitochondrial biogenesis and 
dynamics are relevant mechanisms potentially responsible for mitochondrial dysfunctions. 
PCR and western blotting analyses are pertinent techniques to investigate these pathways in 
human samples with limited size (20 to 30 mg). Major proteins potentially involved in these 
pathways have been described in the previous chapter “Transcriptional regulation of 
mitochondrial oxidative capacity – interaction with fusion-fission dynamics” and can be 
targeted using molecular tools. 
4.10 Investigation of the mitoproteome 
The recent development of genomic tools has considerably improved or knowledge of 
metabolic disorders within key metabolic tissues. Recently, a proteomic study of 
mitochondrial proteins (mitoproteome) reported that more than 80% of ETC proteins can be 
identified (Lefort et al., 2009). The authors were able to reliably detect proteins implicated in 
ROS generation, scavenging, FA oxidation and apoptosis. One hundred micrograms of 
human biopsie are required and allow a more than 7 fold enrichment in mitochondrial 
proteins with a classical isolation procedure as described for respirometry assay. Of note, 
30% of identified proteins from the whole tissue proteome are assigned to mitochondria (Yi 
et al., 2008). Further studies should aim to relate the metabolic disorders and modification of 
the mitoproteome in insulin sensitive and resistant subjects. This tool combined to 
transcriptomic analysis should provide key elements to distinguish between mitochondrial 
functioning defect and mitochondrial density variation during insulin resistance. 
5. Conclusions 
Exploring mitochondrial functioning in muscle samples, especially from human muscle 
biopsies, can be achieved using combination of strategies which require a minimal amount 
of 20mg of tissue for permeabilized fibers for one experimental condition (e.g. respirometry 
with one substrate), 30mg for molecular exploration and 30mg for an enzyme activity. The 
most tissue-consuming techniques are those based on isolated mitochondria, which 
necessitate at least 80mg of tissue for the extraction procedure. Once mitochondrial pellets 
are obtained, if further purification is not performed, combined and miniaturized methods 
allow assessing several parameters characterizing mitochondrial functioning (for example 
respiration, ATP and ROS production and enzyme activities). Hence, 150 to 200mg of tissue 
sample could be considered as a sufficient condition to build a complete investigation as 
presented in figure 4. These explorations are however limited in the number of substrates 
used for testing the ETC. 
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Tissue oxidative capacity
Mitochondrial
functioning
Mitochondrial
biogenesis
Mitochondrial
content
mitochondria in situ
isolated mitochondria
Mitochondrial
dynamics
 
Fig. 4. Main guidelines for exploring mitochondrial functioning in human muscle biopsies. 
6. Supplementary materials: buffers composition and protocols 
6.1 Preservative solution for isolated fibers 
CaK2EGTA 1.9mM, K2EGTA 8.1mM, imidazole 20mM, DTT 0.5mM, MgCl2 9.5mM, MES 
53.3mM, taurine 20mM, ATP 2.5mM, phosphocreatine 19mM, pH 7.1. 
6.2 Mitochondria isolation buffers and procedure 
Tissue grinding: 100mM KCl, 50mM Tris, 5mM MgSO4, 2mM EDTA, 1mM ATP, 0.2% BSA, 
pH 7.4.  To improve the extraction rate of intermyofibrillar mitochondria, treatment with 
subtilisine type VIII (1.5mg/ml, 5ml/g tissue, incubation 2 to 5 min on ice) is required prior 
to homogenization. 
 
tissue minced
To obtain mix of subsarcollemmal and intermyofibrillar mitochondria :
Incubation with protease in ATP buffer, 2 min on ice
Rinse with ATP buffer
polytron homogenate
surpernatant
To discriminate intermyofibrillar mitochondria :
Resuspend in ATP buffer and Polytron
Centrifuge 1000g, 10 min, 4°C
pellet
surpernatantresidue surpernatant pellet
surpernatant
pellet
mitochondria
Centrifuge 1000g, 10 min, 4°C
Centrifuge 4400g, 10 min, 4°C
Resuspend in KCl Buffer
Centrifuge 7000g, 10 min, 4°C
Resuspend in
Sucrose medium
 
Fig. 5. Procedure for isolating subcellular fractions enriched in mitochondria using 
differential centrifugation. 
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KCl buffer: KCl 100mM, Tris 50mM, MgSO45mM, EDTA 2mM, pH 7.4. 
ATP buffer: KCl buffer with ATP 1mM and BSA 0.2%, pH 7.4. 
Protease buffer: ATP buffer with subtilisine type VIII (1.5 mg/ml, 5 ml/g tissue). 
Sucrose medium: sucrose 0.25M, EGTA 0.1mM, Tris-HCl 10mM, pH 7.4. 
6.3 Respiration buffer 
CaK2EGTA 1.9mM, K2EGTA 8.1mM, imidazole 20mM, DTT 0.5mM, KH2PO4 3mM, MgCl2 
4mM, MES 100mM, taurine 20mM, EDTA 20μM and 0.2% BSA. 
6.4 Measurement of mitochondrial ATP production 
Add freshly isolated mitochondria to the reaction medium containing glucose 400 mM, 
MgCl2100 mM, KPO4 100mM, potassium succinate 200mM, AMP 110mM, Hepes 10mM, 
NADP 7.5mM, ADP 50mM, hexokinase 10μg, and glucose-6-P dehydrogenase 10mg. The 
total volume in the cuvette is 1 ml. The increase in absorbance at 340nm is followed at room 
temperature for 3 min (Rustin et al., 1994). 
ATP production can also be assessed using a coupled assay between lactate dehydrogenase 
and pyruvate kinase, NADH reduction being checked at 340 nm. Aliquots of mitochondria 
(20-40 µg protein) are added to a medium (Tris 50mM, BSA 5mg/ml, MgCl2 20mM, KCl 
50mM, carbonyl cyanide m-chlorophenylhydrazone 15µM, antimycin A 5µM, 
phosphoenolpyruvate10mM, ATP 2.5mM, 4 units of lactate dehydrogenase and pyruvate 
kinase, NADH 1mM, pH 8.0) pre-incubated for 5 min at 37°C. The reaction is followed for 3 
min before and after  oligomycin 3µM is added in order to distinguish the ATPase activity 
coupled to the ETC (Short et al., 2001). 
6.5 DNA purification for mtDNA quantification 
Remove the aqueous phase with RNA. Isolate and spun the interphase/organic phase at 
12000×g for 5min at 4°C. Remove the remaining aqueous phase to limit contamination with 
RNA. Add back extraction buffer (4M Guanidine Thiocyanate, 50mM Sodium citrate, 1M 
Tris; 0.5mL per 1mL of Trizol used for RNA extraction) to each tube and mix for 10 min. 
Centrifuge at 12000×g for 30min at room temperature. Incubate the upper phase with 
isopropanol (0.4mL per 1mL of Trizol used for RNA extraction) 5min at room temperature 
and spun at 12000×g for 15 min at 4°C. Pellets which contain DNA are washed twice with 
ethanol 70% and spun at 12000×g for 15min at 4°C. Final dissolution is done with sterile 
water after ethanol removal. DNA concentration is determined spectrophotometrically at 
260nm. Total DNA solutions could be stored at -20°C. 
6.6 Maximal activity of key oxidative enzymes 
Homogeneization buffer for muscle samples: sucrose 0.25mM, EDTA 2mM and Tris-HCl 
10mM, pH 7.4. 
Buffer for assessing β-hydroxyacyl-CoA dehydrogenase activity: Na2HPO4 0.1M, EDTA 
2mM, pH 7.5 adjusted with NaH2PO4 0.1M, EDTA 2mM. Samples are homogenised in buffer 
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(Na2HPO4 0.1M, EDTA 2mM, pH 7.5 adjusted with NaH2PO4 0.1M, EDTA 2mM). 75µl of 
homogenate is added to 925µl of medium (triethanolamine 100mM, EDTA 5mM, 
acetoacetyl-CoA 0.1mM, β-NADH 0.45mM, pH 7) and incubated at 30°C during 2 min 
whilst absorbance is measured at 340nm (Morio et al., 2001). 
6.7 Measurement of fatty acid oxidative capacity 
At least 50mg of fresh muscle sample is cut into small pieces and crushed in the ice-cold 
homogeneization buffer (cf 6.6). Total LCFA oxidation is measured using sealed vials in a 
total volume of 0.5mL containing 75μL of muscle homogenate in a medium (sucrose 25mM, 
Tris-HCl 75mM, KH2PO4 10mM, MgCl2 5mM, EDTA 1mM, pH 7.4) supplemented with ATP 
5mM, NAD+ 1mM, coenzyme A 0.1mM, L-carnitine 0.5mM, L-malate 0.5mM and 
cytochrome c 25μM. Peroxisomal LCFA oxidation is determined in the presence of 
mitochondrial oxidation inhibitors (rotenone and antimycin A) in a medium lacking L-
carnitine and L-malate. Blanks are produced by replacing the muscle homogenate with 
homogeneization buffer. 
After 5 min of pre-incubation at 37°C under shaking, the reaction is started by injecting 
0.1mL of 600μM of the radiolabelled [14C] fatty acid. Incubation is carried out at 37°C for 30 
min and stopped by the addition of 0.2mL of 3M perchloric acid. After 90 min at 4°C, the 
acid incubation mixture is centrifuged for 5 min at 10,000 g, and the 0.5mL supernatant 
containing 14C-labelled perchloric acid-soluble products is assayed for radioactivity by 
liquid scintillation. LCFA oxidation rate is calculated from 14C-labelled perchloric acid-
soluble products and expressed in nmoles of fatty acids oxidized per minute per gram wet 
tissue weight. Mitochondrial oxidation rate is calculated by subtracting the peroxisomal rate 
from the total oxidation rate. Of note, 14CO2 production can be trapped in 0.3mL 
ethanolamine/ethylene glycol (1:2, v/v) and measured by liquid scintillation. 
6.8 Measurement of CPT-1 activity 
CPT-1 activity is measured from freshly isolated mitochondria (0.1mg of protein/ml) at 
30°C from palmitoyl-L-[methyl-3H]carnitine formed from L-[methyl-3H]carnitine (200µM; 
10Ci/mol) and palmitoyl-CoA (80µM) in the presence of 1% (w/v) BSA. Increasing 
concentration of malonyl-CoA (from 0.01 to 600µM) are used for the estimation of the IC50 
value (concentration of malonyl-CoA required to achieve 50% inhibition if CPT-1 activity). 
This method measures the amount of palmitoyl-carnitine produced from palmitoyl-CoA 
and carnitine and is originately described by Kim et al. (2000). 
CPT-1 maximal activity on fresh whole muscle homogenates: 50mg of muscle is 
homogenized in ice-cold incubation buffer containing KCl 75mM, Hepes 5mM, KCN 2mM, 
EGTA 0.2mM, DTT 1mM, ATP 5mM, pH 7.3. Fifty microliters of a 5-fold diluted muscle 
homogenate are preincubated for 5 min at 30°C with 350µl of incubation buffer and 100µl of 
80µM palmitoyl-CoA. Reactions are initiated when 50µl of 10mM L-[3H]carnitine (1µCi) are 
added at 30°C for 15 min. The reaction is terminated with 1ml of isobutanol. The formed 
[3H]palmitoyl-carnitine is extracted with saturated SO4(NH4)2 and counted by liquid 
scintillation. CPT I activity is expressed in nanomoles [3H]palmitoyl-carnitine per gram of 
wet tissue per minute corrected for malonyl-CoA (0.3mM)-insensitive [3H]palmitoyl-
carnitine synthesis (Rimbert et al., 2004). 
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